{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:39:27Z","timestamp":1765960767129,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.4158\/ep13102.cr","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T22:40:01Z","timestamp":1378507201000},"page":"e158-e162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hypercalcemia Secondary to Gastrointestinal Stromal Tumors: Parathyroid Hormone-Related Protein Independent Mechanism?"],"prefix":"10.1016","volume":"19","author":[{"given":"Prathima","family":"Jasti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipul Tulsi","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn McCrystal","family":"Dahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP13102.CR_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"New Engl J Med"},{"key":"10.4158\/EP13102.CR_bb0015","first-page":"1585","article-title":"Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis","volume":"27","author":"Al-Moundhri","year":"2006","journal-title":"Saudi Med J"},{"key":"10.4158\/EP13102.CR_bb0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2265.2006.02682.x","article-title":"Hypercalcaemia in a patient with a gastrointestinal stromal tumour","volume":"66","author":"Beckers","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP13102.CR_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clon.2008.02.002","article-title":"Metastatic gastrointestinal stromal tumour presenting as hypercalcaemia \u2014 a rare occurrence","volume":"20","author":"George","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.4158\/EP13102.CR_bb0030","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/bjs.4352","article-title":"Gastrointestinal stromal tumours","volume":"90","author":"Connolly","year":"2003","journal-title":"Br J Surg"},{"key":"10.4158\/EP13102.CR_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004280000338","article-title":"Gastrointestinal stromal tumors--definition, clinical, histological, immunohisto- chemical, and molecular genetic features and differential diagnosis","volume":"438","author":"Miettinen","year":"2001","journal-title":"Virchows Arch"},{"key":"10.4158\/EP13102.CR_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0140-6736(92)90220-W","article-title":"Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia","volume":"339","author":"Ratcliffe","year":"1992","journal-title":"Lancet"},{"key":"10.4158\/EP13102.CR_bb0045","first-page":"607","article-title":"Differences in bone and vitamin D metabolism between primary hyper-parathyroidism and malignancy-associated hypercalcemia","volume":"81","author":"Nakayama","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13102.CR_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00365520310007774","article-title":"Expressions of parathyroid hormone-related protein (PTHrP) and PTH\/ PTHrP-receptor (PTH\/PTHrP-R) in gastrointestinal stromal tumours (GISTs), leiomyomas and schwannomas","volume":"39","author":"Yoshizaki","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.4158\/EP13102.CR_bb0055","first-page":"104","article-title":"The comparison of parathyroid hormone degradation effect by various protease inhibitors in blood specimen","volume":"29","author":"Kim","year":"2009","journal-title":"Korean J Lab Med"},{"key":"10.4158\/EP13102.CR_bb0060","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198012113032401","article-title":"Biochemical evaluation of patients","volume":"303","author":"Stewart","year":"1980","journal-title":"New Engl J Med"},{"key":"10.4158\/EP13102.CR_bb0065","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/endo-124-5-2057","article-title":"Suppression of serum 1,25-dihydroxyvitamin D in humoral hypercalcemia of malignancy is caused by elaboration of a factor that inhibits renal 1,25-dihydroxyvitamin D3 production","volume":"124","author":"Fukumoto","year":"1989","journal-title":"Endocrinology"},{"key":"10.4158\/EP13102.CR_bb0070","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/jc.2012-1357","article-title":"A case of severe 1,25-dihydroxyvitamin D-mediated hypercalcemia due to a granulomatous disorder","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13102.CR_bb0075","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"141","article-title":"Vitamin D: Production, Metabolism, Mechanism of Action, and Clinical Requirements","author":"Bikle","year":"2009"},{"key":"10.4158\/EP13102.CR_bb0080","first-page":"888","article-title":"Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase","volume":"86","author":"Zehnder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13102.CR_bb0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials","volume":"19","author":"Major","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP13102.CR_bb0090","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1200\/JCO.2012.41.7923","article-title":"Denosumab for the treatment of bisphosphonate-refractory hypercalcemia","volume":"30","author":"Boikos","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP13102.CR_bb0095","first-page":"3817","article-title":"Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231","volume":"25","author":"Saito","year":"2005","journal-title":"Anticancer Res"},{"key":"10.4158\/EP13102.CR_bb0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/med.21258","article-title":"FMS kinase inhibitors: current status and future prospects","volume":"33","author":"El-Gamal","year":"2013","journal-title":"Med Res Rev"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2043126X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2043126X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/DG0W78L4X1570122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:04Z","timestamp":1761515824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2043126X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1530891X2043126X"],"URL":"https:\/\/doi.org\/10.4158\/ep13102.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercalcemia Secondary to Gastrointestinal Stromal Tumors: Parathyroid Hormone-Related Protein Independent Mechanism?","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP13102.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}